Prospective study for assessing the disease activity of Crohn's disease by using LRG and fecal calprotectin.
Not Applicable
- Conditions
- Crohn's disease
- Registration Number
- JPRN-UMIN000049128
- Lead Sponsor
- agoya University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients under 20 years old Contraindicated patients for endoscopy Patients with autoimmune diseases other than inflammatory bowel disease Patients with malignancy Patients that the doctor deems inappropriate
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Predictive ability of LRG and fecal calprotectin for mucosal healing in Crohn's disease.
- Secondary Outcome Measures
Name Time Method Correlation between LRG or fecal calprotectin and endoscopic activity in Crohn's disease.